proteins, rabbit platelets could be labeled adequately in vitro with radioiodine. 2. Platelets thus labeled in vitro did not promote clot retraction and disappeared rapidly from the circulation on reinjection. 3. The prob- able reason for the failure of the tagged plate- lets to survive following reinjection is injury to the platelets, resulting from the separation and concentration technics. 4. Since separa- tion of platelets from plasma proteins is essen- tial for I181 labeling, this method does not appear adaptable to studies of the in vivo

metabolism of normal platelets.

1. Mueller, J. E., PROC. Soc. EXP. BIOL. AND MED., 1953, v83, 557.

2. Julliard, J., Blaupin, B., Loverdo, A., (ab) J.A.M.A., 1952, v149, 1508.

3. Minor, A. H., and Burnett, L., Blood, 1952, v7, 693.

4. Pressman, J., J. Immunol., 1950, v66, 609.

5. Wintrobe, M. M., Clinical Hematology, 3rd Edition, Lea and Febiger, Philadelphia, 1951, p239.

Received February 4, 1954. P.S.E.B.M., 1954, v85.

Glucocorticoids in Adrenocortical Carcinoma of Mice. (20903)

KARL E. PASCHKIS, A. CANTAROW, AND R. A. HUSEBY .*

From Divisions of Endocrine and Cancer Research, Jefferson Medical College, and of Cancer Biology, Department of Physiology, University of Minnesota Medical School.

Adrenocortical hyperplasia or carcinoma is observed in certain inbred strains of mice following early castration(1,2). In guinea pigs a nodular hyperplasia of the adrenal cortex following castration has been reported (3). Both the hyperplastic and the cancerous adrenals have been shown to secrete sex hormones, as evidenced by changes in the uterus and vagina(4), the prostate and sem- inal vesicles(5,3), the submaxillary gland and kidney(6) and the breast(4). Urinary secre- tion of estrogens has been studied in ovariecto- mized mice with adrenocortical tumors(7). Dickie and Woolley have studied the pituitary changes, especially with regard to the baso- philic cells, in mice with postcastration ad- renocortical cancers; they suggest that the syndrome in mice may well be an animal counterpart of Cushing’s syndrome in man. Whereas no cell types in the mouse pituitaries were identified as exact counterparts of Crooke’s changes, certain observed cell changes were considered in some respects similar to those described by Crooke, which in man are characteristic of Cushing’s syndrome (8). Recent observations concerning the occurrences of Crooke’s changes in individuals

treated with cortisone suggest that in Cush- ing’s syndrome the Crooke’s changes are the result of the excessive secretion of C11-C17 oxygenated adrenal steroids(9.10). In the mouse, evidence has been presented heretofore only for sex steroid secretion by these adreno- cortical carcinomas. It therefore appeared desirable to examine them for the presence of C11 oxygenated steroids.

Materials and methods. Adrenal cancers were induced in Minneapolis (a) in F1 hy- brids of AxCE mice and transplanted into hybrids as described elsewhere (11) (first transplant generation from 3 primary tu- mors), and (b) in CE mice, with transplanta- tion into the same strain (pool second trans- plant generation from 4 primary tumors). The mice were shipped to Philadelphia, where the tumors were harvested when they had reached an appropriate size. The tumors were dissected out, weighed and homogenized in a Potter homogenizer. The homogenate was used for bioassay of “corticoids”, by the mouse liver glycogen method of Venning (12). The tissue homogenate was mixed directly with the glucose-alcohol in some instances; in others an acetone extract was prepared, and the dried extract dissolved in alcohol and added to the glucose. In one experiment, 30

* Present address: Department of Surgery, Uni- versity of Colorado School of Medicine, Denver, Colo.

TABLE I. Glucocorticoids in Adrenal Carcinoma of Mice. 6 experiments.
Origin of tumorWt of tumor (mg)Equiv. of Compound A acetateAssay
In total tumorPer 100 mg tumor
AxCE215In fresh homogenate
"240idem
"73819025idem
"1968.81809.1On acetone extract of homogenate
",60002644.4idem
CE535072013.4idem, incubated 2 hr*

* This procedure was performed because this experiment served as control for the incubation of tumor homogenate with desoxycorticosterone glucoside (see text).

mg of desoxycorticosterone glucoside was added to 5.35 g homogenate in Krebs buffer solution, and the mixture incubated in oxygen for 2 hours with constant shaking. This was followed by acetone extraction; the dried acetone extract was assayed as indicated above. A group of 47 control mice (hybrid white mice obtained from a local dealer) were sacrificed and the adrenals pooled and homo- genized. Assay of the fresh homogenate was performed as indicated above for the tumors. Assay values were read against a standard dose-response curve with either compound A acetate or cortisone acetate.

Results. 1. Results of the assays of the tumors are summarized in Table I. Gluco- corticoids were demonstrable in all instances.

2. An assay of the glucocorticoid content of normal mouse adrenals yielded 190 µg equivalent of Compound A acetate in 206.8 mg adrenal tissue, representing 47 pairs of mouse adrenals; the concentration was 90 µg per 100 mg adrenal tissue, or 4 µg per pair of adrenals.

3. Incubation of 30 mg desoxycorticosterone glucoside with 5350 mg adrenal tumor homo- genate for 2 hours failed to yield additional glucocorticoids; the assay value was 816 ug equivalent of Compound A acetate, as against 720 µg equivalent in the incubated homo- genate without addition of DOCG.

Discussion. Glucocorticoids were demon- strable in the adrenocortical carcinomas. The values obtained may be considered as minimal values; in the larger tumors necrotic areas were detectable grossly and although as much as possible was excised prior to homogeniza- tion, very probably some residual necrotic material was included. In the normal ad-

renals, medulla and cortex could not be sep- arated. The values for hormone concentra- tion, expressed as µg per 100 mg adrenal- or tumor tissue, are therefore of limited signifi- cance, but it would appear that the concen- tration in the normal adrenals is higher than in the tumor. On the other hand the amount of hormone present in an individual mouse is 50-100 times greater in tumor-bearing than in normal mice. In 2 of the tumor-bearing mice (Exp. 1 and 2) blood sugars were deter- mind and were found to be 82 and 106 mg/ 100 ml, respectively. If the hormone content of the tumor reflects a comparable release of glucocorticoids into the circulation, it is per- haps remarkable that these mice were normo- glycemic. Little is known regarding the sen- sitivity of mice to the diabetogenic action of cortical hormones; Furth has observed dia- betes in mice with adrenocortical hyperplasia due to pituitary tumors(13). Perhaps the simultaneous secretion of sex steroids may counterbalance the effect of glucocorticoid ex- cess in our experiments.

The fact that no conversion of 11-desoxy- corticosterone to a glucocorticoid could be demonstrated, may suggest a different mode of synthesis in the tumors as compared to normal adrenal tissue. The latter, obtained from beef, can oxidize the steroid molecule at C11(14). No comparable data for normal mouse adrenals are available. However, our incubation mixture was not reinforced with ATP, fumarate and magnesium ions, which increase conversion(14). In the absence of these agents, maximum conversion would not be expected, but the complete absence of con- version in the mouse adrenal tumor is prob- ably significant.

The observation that these adrenocortical carcinomas which have been known to secrete sex hormones, also contain appreciable amounts of glucocorticoids, is of interest in view of the findings of Dickie and Woolley on the pituitaries of mice bearing adrenocortical cancers(8). The changes which they found in the pituitary basophils in these mice re- sembling those in human cases of Cushing’s syndrome, may perhaps be correlated with glucocorticoid secretion by the cortical tumors rather than with the sex hormone secretion. In man, changes in the pituitary basophils, especially the hyaline changes described by Crooke, are characteristic of Cushing’s syn- drome and have also been found in the pitui- taries of individuals treated with large doses of cortisone(9,10). It is of interest too that an elevated level of formaldehydogenic ster- oids in the urine has been observed in some instances of adrenogenital syndrome due to adrenocortical carcinoma in women, although the clinical picture gave no evidence of exces- sive glucocorticoid effects. One may draw a tentative parallel to the mouse adrenocortical cancers reported in this paper.

Summary. Adrenocortical carcinomas, in- duced in mice by early castration, and trans- planted to recipient mice, were assayed for glucocorticoids by the mouse liver glycogen method of Venning. Glucocorticoids were present in all tumors. The hormone content of

the tumors was compared with that of normal mouse adrenals and was found to be smaller on the basis of tissue weight. Incubation of tumor homogenate with desoxycorticosterone glucoside failed to yield increased glucogenic activity.

1. Fekete, E., Wooley, G., and Little, C. C., J. Exp. Med., 1941, v74, 1.

2. Woolley, G. W., and Little, C. C., Cancer Res., 1945, v5, 193.

3. Spiegel, A., Arch. f. pathol. Anatomie, 1939, v305, 367.

4. Gardner, W. U., Cancer Res., 1941, v1, 632.

5. Frantz, M. J., and Kirschbaum, A., PROC. Soc. EXP. BIOL. AND MED., 1948, v74, 357.

6. Cancer Res., 1949, v9, 257.

7. Dorfman, R. I., and Gardner, W. U., Endocri- nology, 1944, v34, 421.

8. Dickie, M. M., and Woolley, G. W., Cancer Re- search, 1949, v9, 372.

9. Golden, A., Bondy, P. K., and Sheldon, W. H., PROC. Soc. EXP. BIOL. AND MED., 1950, v74, 455.

10. Laqueur, G. L., Science, 1950, v112, 429.

11. Huseby, R. A., and Bittner, J. J., Cancer Res., 1950, v10, 226.

12. Venning, E. H., Kazmin, V. E., and Bell, J. C., Endocrinology, 1946, v38, 791.

13. Furth, J., Gadsen, E. L., and Upton, A. C, PROC. SOC. EXP. BIOL. AND MED., 1953, v84, 253.

14. Hayano, M., Dorfman, R. I., and Yamada, E. Y., J.B.C., 1951, v193, 175.

Received February 4, 1954. P.S.E.B.M., 1954, v85.

Development of Experimental Exophthalmos in Scorbutic Guinea Pigs .* (20904)

ARTHUR W. LUDWIG. (Introduced by Paul Klemperer.) (With the technical assistance of Darren K. Chen.)

From the Departments of Pathology and of Endocrinology, Medical Service, Mount Sinai Hospital, New York City.

Since the publication of Wolbach’s classic investigation of scurvy(1,2), it has been ac- cepted that in the scorbutic state there is a deficiency in the formation of mesenchymal

intercellular substances. Production of both major elements of the connective tissue inter- cellular material, the fibrillar components as well as the amorphous ground substance, has been reported to be diminished or absent. There has been ample confirmation of the fact that collagen fibre formation in scurvy

* This work was supported by grants from the Life Insurance Medical Research Fund and the U. S. Public Health Service.